Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
Cyclophilins play a key role in the life cycle of many viruses and represent important drug targets for broad-spectrum antiviral therapies. Here, the authors use fragment-based drug discovery to develop non-peptidic inhibitors of human cyclophilins with high activity against replication of a number...
Guardado en:
Autores principales: | Abdelhakim Ahmed-Belkacem, Lionel Colliandre, Nazim Ahnou, Quentin Nevers, Muriel Gelin, Yannick Bessin, Rozenn Brillet, Olivier Cala, Dominique Douguet, William Bourguet, Isabelle Krimm, Jean-Michel Pawlotsky, Jean- François Guichou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39ec7c8e931548f1a43d8bd4de43a06f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
por: Stéphane Chevaliez, et al.
Publicado: (2009) -
Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.
por: Clémentine Aguirre, et al.
Publicado: (2014) -
Mycobacterium tuberculosis cyclophilin A uses novel signal sequence for secretion and mimics eukaryotic cyclophilins for interaction with host protein repertoire.
por: Asani Bhaduri, et al.
Publicado: (2014) -
PpiA, a surface PPIase of the cyclophilin family in Lactococcus lactis.
por: Nicolas Trémillon, et al.
Publicado: (2012) -
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells
por: Christophe Chopard, et al.
Publicado: (2018)